BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 9698220)

  • 1. Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome.
    Thomas X; Thiebaut A; Olteanu N; Danaïla C; Charrin C; Archimbaud E; Fiere D
    Hematol Cell Ther; 1998 Jun; 40(3):119-28. PubMed ID: 9698220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute lymphoblastic leukemia with Philadelphia chromosome: eight case reports].
    Laatiri MA; Chehata S; Amouri A; Sendi HS; Saad A; Ennabli S
    Tunis Med; 2001 Jan; 79(1):38-41. PubMed ID: 11332342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience.
    Thomas X; Olteanu N; Charrin C; Lhéritier V; Magaud JP; Fiere D
    Am J Hematol; 2001 Jun; 67(2):73-83. PubMed ID: 11343378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Bao L; Jiang B; Huang XJ; Wang DB; Qiu JY; Lu XJ; Chen H; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):31-4. PubMed ID: 15946506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics and outcomes of 59 patients with acute lymphoblastic leukemia positive for BCR/ABL].
    Liu Z; Liu XL; Du QF; Xu N; Zhong M; Song LL; Yi ZS; Liu QF; Meng FY; Zhou SY
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):512-5. PubMed ID: 19304540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia.
    Specchia G; Pastore D; Carluccio P; Liso A; Mestice A; Rizzi R; Ciuffreda L; Pietrantuono G; Liso V
    Ann Hematol; 2005 Nov; 84(12):792-5. PubMed ID: 16047203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
    Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X;
    Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute lymphoblastic leukemia in adults. Apropos of 42 cases].
    Laatiri MA; Chehata S; Amouri A; Bouaouina N; Gayed C; Saad A; Ennabli S
    Tunis Med; 2000 Feb; 78(2):115-9. PubMed ID: 10894047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial.
    Thomas X; Boiron JM; Huguet F; Dombret H; Bradstock K; Vey N; Kovacsovics T; Delannoy A; Fegueux N; Fenaux P; Stamatoullas A; Vernant JP; Tournilhac O; Buzyn A; Reman O; Charrin C; Boucheix C; Gabert J; Lhéritier V; Fiere D
    J Clin Oncol; 2004 Oct; 22(20):4075-86. PubMed ID: 15353542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial.
    Martino R; Bellido M; Brunet S; Altés A; Sureda A; Guárdia R; Aventín A; Nomdedéu JF; Domingo-Albós A; Sierra J
    Haematologica; 1999 Jun; 84(6):505-10. PubMed ID: 10366793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
    Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial.
    Hunault M; Truchan-Graczyk M; Caillot D; Harousseau JL; Bologna S; Himberlin C; Guyotat D; Berthou C; Casassus P; Baranger L; Béné MC; Ifrah N; Gyan E;
    Haematologica; 2007 Dec; 92(12):1623-30. PubMed ID: 18055985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of Philadelphia chromosome-positive adult acute lymphoblastic leukemia].
    Zhang YF; Chen ZM; Lou JY; Ni WM; Wang YG; Meng HT; Tong HY; Qian WB; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):814-8. PubMed ID: 22339953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
    Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF
    Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.
    Boissel N; Auclerc MF; Lhéritier V; Perel Y; Thomas X; Leblanc T; Rousselot P; Cayuela JM; Gabert J; Fegueux N; Piguet C; Huguet-Rigal F; Berthou C; Boiron JM; Pautas C; Michel G; Fière D; Leverger G; Dombret H; Baruchel A
    J Clin Oncol; 2003 Mar; 21(5):774-80. PubMed ID: 12610173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center].
    Doubek M; Mayer J; Korístek Z; Protivánková M; Brychtová Y; Oborilová A; Král Z; Klabusay M; Tomíska M; Buchtová I; Vorlícek J
    Cas Lek Cesk; 2002 Mar; 141(4):122-6. PubMed ID: 12046256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute leukemia in the elderly patient. Forty case reports].
    Laatiri MA; Chehata S; Ajmi F; Amouri A; Bouaouina N; Saad A; Ennabli S
    Tunis Med; 2000; 78(8-9):503-7. PubMed ID: 11190727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.